Palestinian German Congress in Dental Sleep Medicine & Temporomandibular Disorders
Temporomandibular disorders (TMDs)
is a term for pain and dysfunction involving the masticatory muscles and the temporomandibular joints (TMJs) and is the most common orofacial pain condition. Prominent features are regional pain in the face and preauricular area, limitations in jaw movements, and noise from the TMJs during jaw movements. TMD affects up to 15% of adults, with a peak incidence at 20 to 40 years of age. Chronic pain is the overwhelming reason for patients with TMD treatment. TMD can be associated with impaired general health, depression and other psychological disabilities and affect quality of life and well-being of the patent.
The recently published Diagnostic Criteria for TMD (DC/TMD) have been found to be reliable and valid. These criteria include the most common types of TMDs including pain-related disorders, such as myofascial pain, headache attributed to TMD, arthralgia, as well as disorders associated with the TMJ, primarily disc displacements and degenerative disease.
Obstructive sleep apnea (OSA)
is a disorder in which recurrent closure of the upper airways occur during sleep. It is characterized by repetitive episodes of complete (apnea) or partial (hypopnea) upper airway obstruction occurring during sleep. Whereas apnea is complete cessation of airflow, hypopnea is characterized by a 70% reduction of airflow for ≥10 seconds or any reduction in airflow that is associated with either an arousal from sleep or a ≥3% arterial oxygen desaturation. These frequent arousals are the primary cause of excessive daytime somnolence, are associated with impaired daytime cognitive function, and are recognized as a cofactor in the etiology of road traffic accidents. Sleep apnea may also be associated with increased cardiovascular and increased cerebrovascular morbidity and mortality. An estimated 82% of men and 92% of women with moderate to severe sleep apnea remain undiagnosed.